Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).

@article{BrookmanMay2013TimeTR,
  title={Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).},
  author={Sabine D. Brookman-May and Matthias May and Shahrokh F Shariat and Giacomo Novara and Richard E Zigeuner and Luca Cindolo and Ottavio de Cobelli and Cosimo De Nunzio and Sascha A. Pahernik and Manfred P Wirth and Nicola Longo and Alchiede Simonato and Sergio Serni and Salvatore Siracusano and Alessandro Volpe and Giuseppe Morgia and Roberto Bertini and Orietta Dalpiaz and Christian Stief and Vincenzo Ficarra},
  journal={BJU international},
  year={2013},
  volume={112 7},
  pages={909-16}
}
OBJECTIVES To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival (CSS) after recurrence in patients with renal cell carcinoma (RCC) undergoing radical nephrectomy or nephron-sparing surgery. To analyse differences in clinical and histopathological criteria between patients with early and late recurrence. PATIENTS AND METHODS Of 13,107 patients with RCC from an international multicentre database, 1712 patients developed recurrence in the follow-up (FU), at a… CONTINUE READING